A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2004
11/03/2004	CN1541657A Medicinal periplaneta americana extracturm extracting process
11/03/2004	CN1541654A Donkey-hide gelatin freeze-dry powder capsule and its process
11/03/2004	CN1541653A Kudzu vine capsule for regulating blood pressure and blood fat, its preparation process
11/03/2004	CN1541651A Unit dosage glycyrrhizicacid diammonium freeze-dry powder injection formulation and its preparation method
11/03/2004	CN1541650A Chronic bronchitis treating traditional Chinese medicine
11/03/2004	CN1541649A Vincristine sulfate liposome drug and its preparation process
11/03/2004	CN1541648A Sodium bisulfate andrographolide aseptic powder for injection and its preparation method
11/03/2004	CN1541647A Di-acetyl-aminoethyl-ethylenediamine powder injection and its preparation method
11/03/2004	CN1541645A Brufen derivative production method and uses
11/03/2004	CN1541644A Fluoxetine enteric coated tablet
11/03/2004	CN1541577A Electronic nonflammable spraying cigarette
11/03/2004	CN1541568A Sea cucumber slice and its preparation method
11/03/2004	CN1541526A Highly effective, non-combustible, inexplosive, and shaking-free environment-friendly type aerosol propellant
11/03/2004	CN1173743C Compositions for treatment of disorders of the oesophagus
11/03/2004	CN1173742C Sustained release medicinal compositions
11/03/2004	CN1173739C Human growth hormone-containing aqueous pharmaceutical composition
11/03/2004	CN1173729C Aloe product and its preparing method
11/03/2004	CN1173721C External-use ointment
11/03/2004	CN1173719C Preparation of hemorrhoids treating capsule
11/03/2004	CN1173712C Compound preparation containing medicinal active bacteria and its preparation
11/03/2004	CN1173711C Donkey-hide gelatin capsule
11/03/2004	CN1173703C Pharmaceutical composition
11/03/2004	CN1173702C Glucocorticoid containing pharmaceutical inhalant powder and method for sterilizing the powder
11/03/2004	CN1173701C Orally disintegrating composition containing mirtazapine
11/03/2004	CN1173700C Compositions and methods for amelioration of human female sexual dysfunction
11/03/2004	CN1173698C Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth citrate basic and ulcerlmin
11/03/2004	CN1173695C Controlled release and odor masking oral pharmaceutical compositions
11/03/2004	CN1173694C Pharmaceutical composition for treatment of acute disorders
11/03/2004	CN1173685C Cosmetic compositions for the prevention and therapy of hair loss
11/03/2004	CN1173640C Nutritive health-care food
11/02/2004	US6813519 Ambulatory medical apparatus and method using a robust communication protocol
11/02/2004	US6812362 Amidation; efficiency, higher yields, performed at or near room temperature, energy savings
11/02/2004	US6812254 Pain reliever and method of use
11/02/2004	US6812220 Pharmaceutical compositions and methods relating to fucans
11/02/2004	US6812204 Delivery of an agent
11/02/2004	US6812025 Detection of preferential enzyme inhibitors; obtain sample containing enzyme, incubate with modulator and nucleotide sequences, monitor amplification of preferential nucleotide sequences, absence of sequences indicates modulator
11/02/2004	US6811795 Solvent extraction of material from glinus lotoides, ruta chalepensis, hagenia abyssinica, and/or millettia ferruginea
11/02/2004	US6811794 Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
11/02/2004	US6811793 Tablet that includes stevia, water soluble binder, water soluble lubricant, active agent, and effervescent agent.
11/02/2004	US6811792 Solid dose delivery vehicle and methods of making same
11/02/2004	US6811784 Recombinant parainfluenza virus expression system and vaccines
11/02/2004	US6811768 Use of inhaled NO as anti-inflammatory agent
11/02/2004	US6811767 Liquid droplet aerosols of nanoparticulate drugs
11/02/2004	US6811549 Administration of therapeutic or diagnostic agents using interlabial pad
11/02/2004	US6811534 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
11/02/2004	US6811533 Ambulatory medical apparatus and method using a robust communication protocol
11/02/2004	US6810874 Two or more powder containers for different drug powders which can be inhaled as a combined medication
11/02/2004	CA2364251C Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
11/02/2004	CA2338704C Oral liquid mucoadhesive compositions
11/02/2004	CA2283676C Stimulation, culture and preservation of pancreatic and other cells
11/02/2004	CA2245693C Nail growth-promoting formulations
11/02/2004	CA2138921C Method of producing a concentrate of anti-d immunoglobulin g and pharmaceutical preparation which contains it
11/02/2004	CA2112014C Antiallergic composition for ophthalmic or nasal use
10/2004
10/30/2004	CA2431742A1 Formulations for anaesthetic use
10/28/2004	WO2004092731A1 Element having bioactive substance fixed thereto
10/28/2004	WO2004092394A2 Fluid planar lipid layer-based membrane-anchored ligand system with specific binding pair members and methods of use thereof
10/28/2004	WO2004092231A2 Macromolecules auto-assembled and photopolymerised around carbon nanotubes a method for production and application thereof
10/28/2004	WO2004091770A1 Encapsulation system
10/28/2004	WO2004091723A1 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
10/28/2004	WO2004091714A2 Implantable or insertable medical devices containing radiation-crosslinked polymer for controlled delivery of a therapeutic agent
10/28/2004	WO2004091700A1 Cartridge injection appliance, cartridge, and injection appliance set for ophthalmic use with the injection appliance
10/28/2004	WO2004091697A1 System and method for monitoring power source longevity of an implantable medical device
10/28/2004	WO2004091667A1 Uptake of macromolecules
10/28/2004	WO2004091665A1 Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist
10/28/2004	WO2004091640A1 Skin protecting compositions
10/28/2004	WO2004091639A2 Lipid extract from fruit of low lipid content
10/28/2004	WO2004091633A1 Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.o]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof
10/28/2004	WO2004091631A1 Androgen pharmaceutical composition and method for treating depression
10/28/2004	WO2004091630A1 Remedies for diseases to be applied to eye
10/28/2004	WO2004091623A1 Pharmaceutical formulations containing methylnaltrexone
10/28/2004	WO2004091622A1 The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome
10/28/2004	WO2004091614A2 Stabilized amlodipine maleate formations
10/28/2004	WO2004091601A1 Floating oral formulations for controlled release of betaine
10/28/2004	WO2004091600A1 Solid preparation for oral use
10/28/2004	WO2004091590A1 Medical active agent patch optically less visible on skin
10/28/2004	WO2004091589A1 Transdermally administerable tranquilizing and sedating agent
10/28/2004	WO2004091588A1 Pharmaceutical composition containing levodopa and carbidopa
10/28/2004	WO2004091587A1 Multiple release anti-diabetic drugs and process of production thereof
10/28/2004	WO2004091586A2 Release system based on a starch network
10/28/2004	WO2004091585A1 Orally disintegrating tablets
10/28/2004	WO2004091584A1 Absorption enhancers such as e.g. bht, bha or propyl gallate
10/28/2004	WO2004091583A1 Chrono delivery formulations and method of treating atrial fibrillation
10/28/2004	WO2004091582A1 Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them
10/28/2004	WO2004091581A1 Radioactively marked microparticles, method for the production thereof and use of the same
10/28/2004	WO2004091580A1 Venlafaxine compositions comprising pellets with double layer coating
10/28/2004	WO2004091579A1 Stabilized prostaglandin formulation
10/28/2004	WO2004091578A2 Novel encochleation methods, cochleates and methods of use
10/28/2004	WO2004091577A1 Composition, method and pharmaceutical preparation for pharmaceutical spray suspensions
10/28/2004	WO2004091576A1 Formulations and methods for treating rhinosinusitis
10/28/2004	WO2004091575A1 Nasal pharmaceutical formulations and methods of using the same
10/28/2004	WO2004091574A1 Nasal pharmaceutical formulations and methods of using the same
10/28/2004	WO2004091572A2 Cochleate compositions directed against expression of proteins
10/28/2004	WO2004091571A2 Polymer coating/encapsulation of nanoparticles using a supercritical antisolvent process
10/28/2004	WO2004091570A1 Method of treatment
10/28/2004	WO2004091553A2 Film forming polymers, methods of use, and devices and applications thereof
10/28/2004	WO2004091550A2 Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives
10/28/2004	WO2004091546A2 Central nervous system stimulant and opioid antagonist combinations
10/28/2004	WO2004091541A2 Methods for the controlled delivery of pharmacologically active compounds
10/28/2004	WO2004091539A2 Fluid mixing methods and apparatus
10/28/2004	WO2004091538A2 Homogeneous, thermoreversible alginate films and soft capsules made therefrom

1 ... 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 1938 ... 2991